Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Kyndryl Holdings Inc (KD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Kyndryl Holdings Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B), while Kyndryl Holdings Inc trades at $11.78 (market cap $2.57B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 12× Kyndryl Holdings Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Kyndryl Holdings Inc pays none. Which is the better fit depends on your goals.
| GEHC | KD | |
|---|---|---|
Market Cap | $30.93B | $2.57B |
Volume | 5,033,451 | 3,294,342 |
Sector | Health | Technology |
52-Week High | $88.16 | $28.92 |
52-Week Low | $59.48 | $10.59 |
Enterprise Value | $39.39B | $5.39B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 36 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Kyndryl (KD) trades at $12.24, up 3.9% on the day, with a neutral technical signal and bearish moving averages. The company reported a return to profitability in 2025 with net income of $252 million, though revenue has declined from prior years. Recent news highlights a strategic focus on AI, including the launch of an innovation lab and an acquisition to bolster healthcare IT services. Positive cash flow generation and a low EV/EBITDA of 3.8 suggest underlying value, but consecutive earnings misses and a high P/E ratio of 31.9 present challenges.
The investment outlook is mixed. A consensus price target of $14.67 implies potential upside, supported by strong operational cash flow and debt reduction. However, risks include declining revenue, thin net margins, and a majority 'Hold' analyst rating. The stock's performance hinges on successful execution of its AI strategy and reversing the top-line contraction seen in recent years.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Kyndryl Holdings Inc
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →
